Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Lisa C. Richardson, MD, MPH

In this session of Beyond the Data, Dr. John Iskander and Dr. Lisa Richardson discuss how establishing a patient’s family history can help health care providers identify genetic mutations that may lead to cancer.

Lisa C. Richardson, MD, MPH, is the Director of CDC’s Division of Cancer Prevention and Control (DCPC). She is responsible for providing leadership and direction for all scientific, policy, and programmatic issues related to four national programs: the Colorectal Cancer Control Program, the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries. She oversees a well-developed research agenda that includes the national Cancer Prevention and Control Research Network.

Dr. Richardson’s previous experience has well-positioned her to lead DCPC. From 1997 to 1998, she served as the medical director for the National Breast and Cervical Cancer and Early Detection Program, which is the only organized screening program for low-income uninsured women in the United States. From 1998 to 2000, she was a medical officer in CDC’s Division of Blood Disorders, where her main responsibility was to monitor new HIV and hepatitis B and C infections among persons with hemophilia. From 2000 to 2004, Dr. Richardson was a faculty member at the University of Florida in Medical Oncology and collaborated extensively with the Florida Cancer Data System, one of the 48 programs funded by CDC’s National Program of Cancer Registries.

Photo of Dr. Lisa C. Richardson

She returned to CDC in 2004 as a medical officer in the Division’s Epidemiology and Applied Research Branch. From 2006 to 2009, Dr. Richardson served as the team lead for Scientific Support and Clinical Translation Team, which supports the National Comprehensive Cancer Control Program. From 2010 to 2013, she served as DCPC’s Associate Director for Science. Her primary responsibilities included collaborating with DCPC’s director in setting scientific priorities and working with Division staff to maintain a high caliber of scientific integrity in public health activities. Her most recent position was the Director of CDC’s Division of Blood Disorders.

Dr. Richardson received her medical degree and Bachelor of Science from the University of North Carolina at Chapel Hill and her Master in Public Health from the University of Michigan, School of Public Health. She completed her internal medicine residency and hematology/medical oncology fellowship at the University of Florida, School of Medicine. She continues to provide clinical services to cancer patients at the Atlanta Veteran’s Administration Medical Center. Dr. Richardson is a Robert Wood Johnson Clinical Scholar and a member of the Alpha Omega Alpha Medical Honor Society.

Dr. Richardson’s education and medical training have shaped her research interests, which range from the caring for the individual to broader public health based system changes. She has authored and coauthored more than 100 peer-reviewed journal articles on breast cancer treatment patterns of care, skin cancer, health policy, access to cancer care, systems of care, health disparities, and racial discrimination.

Dr. Richardson is featured in the following videos—

Dr. Richardson offers her perspective in the following blog posts—

Dr. Richardson is featured in the following podcasts—

Dr. Richardson offers her perspective in the following formatted article (matte release)—

TOP